Abstract LB164: Inducing immunogenic cell death in difficult-to-treat cancers with an orally-bioavailable GPX4 inhibitor

Authors: Timothy J. Read, Richard Steel, Ardeshir Golialei, Jenna Rimel, Leah Damon, Joey Azofeifa

Published: 2024-04-05

DOI: 10.1158/1538-7445.am2024-lb164

Source: Full article